8-K

AXCELIS TECHNOLOGIES INC (ACLS)

8-K 2023-08-02 For: 2023-08-02
View Original
Added on April 08, 2026

UNITED STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section

13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2023

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware 000-30941 34-1818596
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
108 Cherry Hill Drive, Beverly, Massachusetts 01915
--- ---
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:

(978) 787-4000

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

¨ Written<br>communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
¨ Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
¨ Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Securities registered pursuant to Section 12(b) of the Act:

Title<br> of each class Trading<br> Symbol(s) Name<br> of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

Item2.02 Results of Operations and Financial Condition

On August 2, 2023, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended June 30, 2023. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01   Financial Statements and Exhibits.

Exhibit No. Description
99.1 Press Release dated August 2, 2023. Filed herewith.
104 Cover Page Interactive Data File (embedded within the Inline<br>XBRL document)
2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 2, 2023 Axcelis Technologies, Inc.
By: /s/ KEVIN J. BREWER
Kevin J. Brewer
Executive Vice President and Chief Financial Officer
3

Exhibit 99.1

News Release

Axcelis AnnouncesFinancial Results for Second Quarter 2023

FinancialResults Exceed Guidance Driven by Strong Purion Demand and Strength in Power Devices


BEVERLY, Mass. — Aug. 2, 2023 — Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter of 2023.

Highlights include:

· The<br> Company reported second quarter revenue of $274.0 million, compared to $254.0 million for<br> the first quarter of 2023.
· Operating<br> profit for the quarter was $63.7 million, compared to $51.4 million for the first quarter.
--- ---
· Net<br> income for the quarter was $61.6 million, or $1.86 per diluted share, compared to $47.7 million,<br> or $1.43 per diluted share in the first quarter.
--- ---
· Gross<br> margin for the quarter was 43.7%, compared to 40.9% in the first quarter.
--- ---
· Second<br> quarter ended with systems backlog of $1.23 billion on quarterly bookings of $193 million.
--- ---

President and CEO Russell Low commented, “Axcelis delivered strong second quarter financial performance as a result of significant demand for the Purion product family, especially in the silicon carbide power market. Axcelis is the only company with a product line capable of covering all implant recipes in the mature process technology markets. This uniquely positions Axcelis for strong growth. We now believe it is possible to achieve $1.3 billion in revenue in the next one or two years, depending on market conditions.”

Executive Vice President and Chief Financial Officer Kevin Brewer said, “We are very pleased with our second quarter 2023 financial results which finished well above guidance due to solid execution and continuing strong demand for Purion. We are upwardly revising expectations for 2023 revenue to greater than $1.1 billion, representing year over year growth of approximately 20%.”

BusinessOutlook For the third quarter ending September 30, 2023, Axcelis expects revenues of approximately $280 million. Gross margin in the third quarter is expected to be approximately 44%. Third quarter operating profit is forecast to be approximately $64 million with earnings per diluted share of approximately $1.72. For the full year, the Company expects to achieve revenue greater than $1.1 billion and to achieve full year gross margins of approximately 44% as shown in the $1.1 billion model.

News Release

SecondQuarter 2023 Conference Call

The Company will host a call to discuss the results for the second quarter on Thursday, August 3, 2023, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI9757e7e7d17f4188872f4146e314ba26. Webcast replays will be available for 30 days following the call.

SafeHarbor StatementThis press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for revenues, gross margin, operating profit and other guidance for our future financial performance and spending in our industry, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

Company Contacts

Investor Relations:

Doug Lawson

978.787.9552

Editorial/Media:

Maureen Hart

978.787.4266


News Release

Axcelis Technologies, Inc.

ConsolidatedStatements of Operations

(In thousands,except per share amounts)

(Unaudited)


Three months ended Six months ended
June 30, June 30,
2023 2022 2023 2022
Revenue:
Product $ 265,673 $ 213,926 $ 511,680 $ 410,458
Services 8,297 7,251 16,310 14,314
Total revenue 273,970 221,177 527,990 424,772
Cost of revenue:
Product 146,741 115,754 289,512 223,395
Services 7,526 6,242 14,756 12,429
Total cost of revenue 154,267 121,996 304,268 235,824
Gross profit 119,703 99,181 223,722 188,948
Operating expenses:
Research and development 24,130 18,731 47,903 35,704
Sales and marketing 15,537 12,703 29,681 23,994
General and administrative 16,328 13,602 31,073 26,180
Total operating expenses 55,995 45,036 108,657 85,878
Income from operations 63,708 54,145 115,065 103,070
Other income (expense):
Interest income 4,307 352 8,243 447
Interest expense (1,349 ) (1,250 ) (2,702 ) (2,768 )
Other, net (2,050 ) (5,051 ) (3,088 ) (6,669 )
Total other income (expense) 908 (5,949 ) 2,453 (8,990 )
Income before income taxes 64,616 48,196 117,518 94,080
Income tax provision 3,037 4,007 8,242 8,276
Net income $ 61,579 $ 44,189 $ 109,276 $ 85,804
Net income per share:
Basic $ 1.88 $ 1.34 $ 3.34 $ 2.59
Diluted $ 1.86 $ 1.32 $ 3.29 $ 2.54
Shares used in computing net income per share:
Basic weighted average shares of common stock 32,775 33,096 32,759 33,170
Diluted weighted average shares of common stock 33,189 33,562 33,237 33,770
News Release
---

Axcelis Technologies, Inc.

ConsolidatedBalance Sheets

(In thousands,except per share amounts)

(Unaudited)

December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents 132,504 $ 185,595
Short-term investments 320,360 246,571
Accounts receivable, net 159,199 169,773
Inventories, net 299,841 242,406
Prepaid expenses and other current assets 38,265 33,300
Total current assets 950,169 877,645
Property, plant and equipment, net 43,156 39,664
Operating lease assets 31,998 12,146
Finance lease assets, net 17,305 17,942
Long-term restricted cash 6,652 752
Deferred income taxes 38,944 31,701
Other assets 33,494 33,791
Total assets 1,121,718 $ 1,013,641
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable 60,504 $ 62,346
Accrued compensation 17,216 35,540
Warranty 10,867 8,299
Income taxes 6,598 4,304
Deferred revenue 138,890 123,471
Current portion of finance lease obligation 1,367 1,229
Other current liabilities 13,018 12,943
Total current liabilities 248,460 248,132
Long-term finance lease obligation 44,455 45,185
Long-term deferred revenue 43,650 31,306
Other long-term liabilities 41,116 21,762
Total liabilities 377,681 346,385
Stockholders’ equity:
Common stock, 0.001 par value, 75,000 shares authorized; 32,836 shares issued and outstanding at June 30, 2023; 32,775 shares issued and outstanding at December 31, 2022 33 33
Additional paid-in capital 540,120 550,299
Retained earnings 206,813 118,892
Accumulated other comprehensive loss (2,929 ) (1,968 )
Total stockholders’ equity 744,037 667,256
Total liabilities and stockholders’ equity 1,121,718 $ 1,013,641

All values are in US Dollars.